Targeted screening for Alzheimer's disease clinical trials using data-driven disease progression models (2021)
Attributed to:
I-AIM: Individualised Artificial Intelligence for Medicine
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.01.29.21250773
Publication URI: http://dx.doi.org/10.1101/2021.01.29.21250773
Type: Preprint